Circadian Rhythm Deregulation in Patients With CAPS

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 1, 2028

Study Completion Date

November 1, 2028

Conditions
Cryopyrin Associated Periodic SyndromeFamilial Cold UrticariaMuckle-Wells SyndromeCINCA Syndrome
Interventions
GENETIC

Genetic analysis of NLRP3

Blood test for genetic analysis of NLRP3

DEVICE

Circadian rhythm measurement

Wear a Withings Pulse HR (heart rate) actigraphic watch 24 hours a day for 1 month to define circadian rhythm

BIOLOGICAL

Saliva sampling

Saliva sampling for salivary melatonin determination

OTHER

Questionnaire

Questionnaire to determine chronotype

OTHER

AIDAI score

Disease activity score using AIDAI score (only for patients in the CAPS group) AIDAI : AUTO-INFLAMMATORY DISEASE ACTIVITY INDEX

BIOLOGICAL

Blood sampling

"1. Inflammatory cytokines measurement : IL1-beta (Interleukin-1) and IL-18.~2. Molecular characterization of circadian clock signaling pathways"

Trial Locations (6)

59037

Hôpital Claude Huriez (CHU de Lille), Lille

69004

Hôpital de la Croix-Rousse (HCL), Lyon

69437

Hôpital Edouard Herriot (HCL), Lyon

69677

Hôpital Femme-Mère-Enfant (HCL), Bron

75020

Hôpital Tenon (AP-HP), Paris

94270

Hôpital Kremlin-Bicêtre (AP-HP), Paris

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT06544018 - Circadian Rhythm Deregulation in Patients With CAPS | Biotech Hunter | Biotech Hunter